Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Stratification of Liver Disease in the Community Using Fibrosis Biomarkers

NCT02037867 is registered in ClinicalTrials.gov with University of Nottingham as lead sponsor.

NCT NCT02037867
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02037867 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Stratification of Liver Disease in the Community Using Fibrosis Biomarkers
Lead sponsor
University of Nottingham
Phase
Observational
Overall status
Recruiting
Start date
May 31, 2013
Completion date
May 31, 2033
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder, chronic liver disease, obesity, persistently elevated alt, type 2 diabetes